CID 4036900

2-{[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl}-n-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide

Structural Information

Molecular Formula
C16H17N5O3S2
SMILES
CCC1=NN=C(S1)NC(=O)CSC2=NN=C(O2)C3=CC=C(C=C3)OCC
InChI
InChI=1S/C16H17N5O3S2/c1-3-13-18-20-15(26-13)17-12(22)9-25-16-21-19-14(24-16)10-5-7-11(8-6-10)23-4-2/h5-8H,3-4,9H2,1-2H3,(H,17,20,22)
InChIKey
VEKIRRYKWNIKIC-UHFFFAOYSA-N
Compound name
2-[[5-(4-ethoxyphenyl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-(5-ethyl-1,3,4-thiadiazol-2-yl)acetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

391.07727 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 392.084546 185.7
[M+Na]+ 414.066488 196.8
[M-H]- 390.069994 193.0
[M+NH4]+ 409.111093 195.4
[M+K]+ 430.040428 192.1
[M+H-H2O]+ 374.074530 178.0
[M+HCOO]- 436.075471 199.1
[M+CH3COO]- 450.091121 196.3
[M+Na-2H]- 412.051936 184.0
[M]+ 391.07672142 195.0
[M]- 391.07781858 195.0
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.